Investor mix
5 investors on record; lead investors include Hudson Bay Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 1 | 20% |
| Other / undisclosed | 3 | 60% |
Developer of antibody and protein-based biopharmaceuticals
5 investors on record; lead investors include Hudson Bay Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 1 | 20% |
| Other / undisclosed | 3 | 60% |